Long non-coding RNAs (lncRNAs) have been illustrated to function as important regulators in carcinogenesis and cancer progression. However, the roles of lncRNA NNT-AS1 in gastric cancer remain unclear. In the present study, we investigate the 
RNAs (ncRNAs) account for a large proportion of transcriptome, which are divided into short non-coding RNAs and lncRNAs according to their length. Increasing evidences have indicated the extensive biological role of lncRNAs on multiple tumour pathological process, for example proliferation, invasion, metastasis and recrudesce. 9, 10 For the tumorigenesis of GC, more and more lncRNAs have been identified to modulate the pathological process.
For instance, long intergenic non-coding RNA 01296 (LINC01296) acts as oncogenic lncRNA in GC carcinogenesis and aggravates gastric cancer cells progress via LINC01296/miR-122/MMP-9 regulatory pathway.
11
In the pre-experiments of our study, we focus on several candidate lncRNAs, and then we measured the expression levels of these candidate lncRNAs in cancer tissue using RT-PCR. After comparing, we found that the lncRNA NNT-AS1 expression level is upregulated in GC tissue samples and cells. NNT-AS1 has been found to act as oncogene in human cancer. 12 Besides, the roles and molecular mechanism of lncRNA NNT-AS1 on GC tumorigenesis are unknown and never reported. Thus, we choose lncRNA NNT-AS1 as our research object. In the present study, we aim to 
| MATERIALS AND METHODS

| Patient samples
A total of 48 GC samples were collected from August 2015 to July 2017 at The Affiliated Cancer Hospital of Zhengzhou University.
There are no any patients who had received preoperative chemotherapy before this study. The tissues were excised during the surgery and snap-frozen in liquid nitrogen. This study was approved by the Ethic Committee of The Affiliated Cancer Hospital of Zhengzhou University. All written informed consents had been collected from every patient before surgery. 
| Cell culture and transfection
| RNA immunoprecipitation (RIP)
RNA immunoprecipitation (RIP) assays were performed as previously described. 13 Wild-type NNT-AS1 or mutant NNT-AS1 were 
| Statistical analysis
Statistical analyses and data calculation were performed using the ( Figure 1B ). According to median value of NNT-AS1 expression, the whole group was divided into high NNT-AS1 expression group (n = 21) and low NNT-AS1 expression group (n = 27) ( Figure 1C ).
Overall survival rate of GC patients was calculated using KaplanMeier curves and log-rank test, showing that GC patients with high NNT-AS1 levels had poor prognosis than those with low NNT-AS1 level ( Figure 1D ). In summary, the data concluded that lncRNA NNT-AS1 was highly expressed in GC tissues and cells, and the ectopic overexpression indicated poor prognosis of GC patients. Figure 2E, F) . Overall, the above data concluded that NNT-AS1 was mainly located in the cytoplasm, and NNT-AS1 knockdown induced the GC cell cycle progression arrest at G0/G1 phase. . C, According to median value of NNT-AS1 expression, the whole group was divided into high NNT-AS1 expression group (n = 21) and low NNT-AS1 expression group (n = 27). D, Kaplan-Meier curves and log-rank test revealed the overall survival rate of GC patients with high/low NNT-AS1 levels. *** P < .001, ** P < .01 compared to control group that NNT-AS1 combined with miR-424 at 3 0 -UTR with molecular binding ( Figure 4B ). RIP assay indicated that both NNT-AS1 and miR-424 were significantly enriched in Ago2 immunoprecipitate compared to IgG-pellet, suggesting that both NNT-AS1 and miR-424 were in the same RNA-induced silencing complex (RISC) (Figure. 4C ). Besides, biotin-avidin pull-down assay was performed to determine whether miR-424 could directly bind with NNT-AS1.
Results showed that miR-424 directly binds with NNT-AS1 (Figure 4D) . RT-PCR showed that miR-424 was significantly overex- was reversed by the co-transfection of miR-424 inhibitor (Figure 5C ). Pearson's correlation analysis revealed that E2F1 expression was negatively correlated to miR-424 expression in 15 cases of GC patients samples ( Figure 5D ). Overall, these data concluded that NNT-AS1/miR-424 targeted E2F1 protein expression in the cycle progression regulation of GC cells in vitro.
| DISCUSSION
Long non-coding RNAs have recently emerged as an important regulator on transcriptional and post-transcriptional regulation of several diseases, including cancers. [14] [15] [16] LncRNA NNT-AS1 has been found to participate in the tumorigenesis of hepatocellular carcinoma, cervical cancer and colorectal cancer. [17] [18] [19] In the pre-experiments of our study, we found that the lncRNA NNT-AS1 expression level was up-regulated in GC tissue samples and cells.
Besides, the roles and molecular mechanism of lncRNA NNT-AS1
on GC tumorigenesis are unknown and never reported. Thus, we choose lncRNA NNT-AS1 as our research object. In the present study, our study investigates the role of lncRNA NNT-AS1 in gastric cancer (GC) tumorigenesis and identifies the underlying mechanism.
During the carcinogenesis of GC, a great deal of lncRNAs might be abnormally expressed. 20, 21 Generally, the significantly dysregulated lncRNAs might involve the pathological process and exert vital roles by regulating multiple progression. In our study, we found that lncRNA NNT-AS1 was significantly high-expressed in gastric cancer Long non-coding RNAs are a type of non-coding RNA (ncRNA) without protein-coding ability. 24, 25 Up to now, the most common regulatory mechanism for lncRNA is the miRNA 'sponge' theory. In our study, our data indicate that NNT-AS1 harbours miR-424 by Moreover, R-424-5p is found to be up-regulated in GC tissues and cells, and its high-expression could promote the proliferation of GC cells. 27 More than NNT-AS1, other lncRNAs also modulate the cellular process of GC cells. 28 For example, lncRNA SNHG6 is overexpressed in gastric cancer tissues and cell lines, and SNHG6 could epigenetically silence p27 and competitively sponge miR-101-3p to regulate ZEB1. 29 In HCC tumorigenesis, NNT-AS1 knockdown inhibited the HCC cells progression via miR-363 thereby targeting CDK6 expression. 18 Therefore, our study firstly confirmed the oncogenic role of 
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